← Leaderboards
Julia Tcw
Icahn School Of Medicine At Mount Sinai
$8,387,804
Attributed
$13,004,981
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.1M · FY2019–25$10M$7.5M$5M$2.5M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,004,981 · 7
By mechanism
R01$9,453,104 · 4
RF1$2,431,261 · 1
K01$620,649 · 1
R56$499,967 · 1
Top collaborators
- Gao Wang2 shared
- Uwe Beffert1 shared
- Xin He1 shared
- Angela Ho1 shared
- Xiaoling Zhang1 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- O'Jay Stewart$85,521
- Nadejda Mincheva Tsankova$4,976,869
- Eli A Stahl$4,724,401
- Hirofumi Morishita$17,178,343
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
- Leon Maing Tai · University Of Illinois At Chicago$5,935,870
Research focus
Alzheimer&AposS DiseaseMolecularBrainS Disease RiskPathogenesisMicrogliaAffectBrain CellAstrocytesCell TypeRisk VariantGenotypeApolipoprotein EExhibitsPhenotypeLate Onset Alzheimer DiseaseNerve DegenerationVariantSingle-Cell Rna SequencingTranscriptomeNeurogliaGenesModality
Grant awards (18)
FunGen-xQTL: Unraveling the genetic basis of molecular functions in Alzheimer's Disease$3,642,232
R01 · FY2025 · AG
Genetic Mapping of m6A and Pseudouridine RNA Modifications in the Aging Human Brain and Their Impact on Alzheimer's Disease$852,273
R01 · FY2025 · AG
Microglia targeted interventions in prodromal Alzheimer's disease stage$782,066
R01 · FY2025 · AG · contact PI
Elucidating endolysosomal trafficking dysregulation induced by APOE4 in human astrocytes$780,310
R01 · FY2025 · AG · contact PI
Elucidating endolysosomal trafficking dysregulation induced by APOE4 in human astrocytes$29,594
R01 · FY2025 · AG · contact PI
Reelin and Receptor Splicing in Alzheimer's Disease$2,431,261
RF1 · FY2024 · AG
Microglia targeted interventions in prodromal Alzheimer's disease stage$816,586
R01 · FY2024 · AG · contact PI
Elucidating endolysosomal trafficking dysregulation induced by APOE4 in human astrocytes$802,834
R01 · FY2024 · AG · contact PI
Elucidating endolysosomal trafficking dysregulation induced by APOE4 in human astrocytes$78,276
R01 · FY2024 · AG · contact PI
Microglia targeted interventions in prodromal Alzheimer's disease stage$830,339
R01 · FY2023 · AG · contact PI
Elucidating endolysosomal trafficking dysregulation induced by APOE4 in human astrocytes$792,934
R01 · FY2023 · AG · contact PI
Deciphering isogenic APOE isoform dependent neurodegenerative response in human glia$123,012
K01 · FY2023 · AG · contact PI
Elucidating endolysosomal trafficking dysregulation induced by APOE4 in human astrocytes$45,660
R01 · FY2023 · AG · contact PI
Uncovering APOE4 Matrisome endophenotypes using human iPSC-based models$499,967
R56 · FY2022 · AG · contact PI
Deciphering isogenic APOE isoform dependent neurodegenerative response in human glia$123,012
K01 · FY2022 · AG · contact PI
Deciphering isogenic APOE isoform dependent neurodegenerative response in human glia$124,875
K01 · FY2021 · AG · contact PI
Deciphering isogenic APOE isoform dependent neurodegenerative response in human glia$124,875
K01 · FY2020 · AG · contact PI
Deciphering isogenic APOE isoform dependent neurodegenerative response in human glia$124,875
K01 · FY2019 · AG · contact PI